This is a firm fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Navy, to Werfen USA LLC, a manufacturer of in vitro diagnostic equipment and reagents. The contract has a ceiling value of $144,185.64 and a performance period ending on September 30, 2016. The contract does not have a set-aside designation. The contract provides for the delivery of #00027430010 - GEM 4000 products, which are likely specialized medical devices,...
The Department of the Navy Bureau of Medicine and Surgery awarded Werfen USA LLC a $4,827 firm fixed price delivery order for GEM4000 150 tests. The contract has a period of performance through June 16, 2022 in Bedford, Massachusetts and was awarded on the same date without a set-aside designation. As a provider of in vitro diagnostics for hemostasis testing and clinical chemistry, Werfen will deliver its GEM4000 analyzer tests to support the Bureau's medical equipment and laboratory services...
This is a firm-fixed-price purchase order contract awarded by the U.S. Department of the Navy's Bureau of Medicine and Surgery (BUMED) to Werfen USA LLC, a limited liability company that manufactures in vitro diagnostic equipment, reagents, and services. The contract, valued at $78,419.92, is for the delivery of laboratory reagents. It does not have a set-aside designation. Werfen USA LLC is an established prime contractor that holds several Indefinite Delivery/Indefinite Quantity (ID/IQ) and...
The Department of the Navy Bureau of Medicine and Surgery awarded Werfen USA LLC a $4,827 firm fixed price delivery order for GEM4000 150 testing. The prime contractor Werfen USA LLC will provide testing services to the Navy's medical programs under this order, which has a period of performance from August 25 to September 3, 2023 at the contractor's facility in Bedford, Massachusetts. No subcontractors or set aside designations were identified for this small, short-term order in support of the...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Werfen USA LLC, a Bedford, Massachusetts-based manufacturer and supplier of in vitro diagnostic equipment, reagents, and services for clinical laboratories and point-of-care medical settings. The contract, identified as GEM 5000, has a ceiling value of $338,375.90 and an ultimate completion date of March 24, 2029. The contract was awarded on March 25, 2024 and does not have a small business...
This is a firm fixed-price Purchase Order contract awarded by the Bureau of Medicine and Surgery, which is part of the Department of Defense, to Werfen USA LLC, a manufacturer of in vitro diagnostic equipment, reagents, and services. The contract, valued at $114,300.00, provides a Total Service Agreement with an ultimate completion date of September 13, 2026. This contract does not have a set-aside designation. Werfen USA LLC, as the prime contractor, will deliver laboratory analyzers, reagents,...
This is a firm fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of Defense, to Werfen USA LLC for a service contract to provide Werfen Rotem Delta in-vitro diagnostic equipment, reagents, and associated services. The contract has a ceiling value of $7,200 and a period of performance through August 21, 2025. Werfen USA is a manufacturer and supplier of clinical diagnostic equipment and consumables, and holds several...
Werfen USA LLC has been awarded a $9,158.79 firm fixed price delivery order by the Department of the Navy Bureau of Medicine and Surgery for GEM4000 150 TEST services. The contract has no set-aside designation and requires completion by June 19, 2020. The Department of the Navy Bureau of Medicine and Surgery oversees healthcare delivery and medical logistics support for U.S. Navy and Marine Corps personnel. This delivery order was issued under an existing IDIQ vehicle and likely relates to...
Werfen USA LLC was awarded a $7,146.74 firm fixed price delivery order by the Department of the Navy Bureau of Medicine and Surgery for GEM4000 150 TEST. The contract has no set-aside designation and requires completion by December 30, 2019. The Department of the Navy Bureau of Medicine and Surgery oversees healthcare delivery and medical research programs for Navy and Marine Corps service members and their families. Werfen USA LLC will provide testing services from its Bedford, Massachusetts...
The Department of the Navy Bureau of Medicine and Surgery awarded a firm fixed-price purchase order contract to Werfen USA LLC, a manufacturer of in vitro diagnostic equipment, reagents, and services. The $120,825 contract is for the delivery of unspecified products to support the agency's healthcare programs at the Fort Sam Houston location in Texas. The contract is not set aside for any specific business type. Werfen USA LLC provides specialized medical devices, consumables, and support to...